We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
301
Consolidated Edison
ED
$41.4B
$8.01M 0.04%
79,640
-1,506
-2% -$151K
WTS icon
302
Watts Water Technologies
WTS
$11.2B
$7.85M 0.04%
28,100
+796
+3% +$213K
BBIO icon
303
BridgeBio Pharma
BBIO
$16.4B
$7.74M 0.04%
+148,986
New +$7.27M
ANNX icon
304
Annexon
ANNX
$796M
$7.73M 0.04%
2,534,230
BLD
305
DELISTED
TopBuild
BLD
$7.67M 0.04%
19,623
-504
-3% -$201K
ULS icon
306
UL Solutions
ULS
$18.6B
$7.66M 0.04%
108,079
+53,856
+99% +$3.67M
OTIS icon
307
Otis Worldwide
OTIS
$27.9B
$7.51M 0.04%
82,173
-269,963
-77% -$24.5M
BMI icon
308
Badger Meter
BMI
$3.87B
$7.51M 0.04%
42,067
+6,103
+17% +$1.2M
KMI icon
309
Kinder Morgan
KMI
$70.9B
$7.44M 0.04%
262,698
-11,280
-4% -$309K
HOOD icon
310
Robinhood
HOOD
$80.7B
$7.35M 0.04%
51,327
+275
+0.5% +$30K
PHM icon
311
Pultegroup
PHM
$25.2B
$7.35M 0.04%
55,617
+3,737
+7% +$464K
GMED icon
312
Globus Medical
GMED
$11.1B
$7.33M 0.04%
127,929
-43,909
-26% -$2.53M
COP icon
313
ConocoPhillips
COP
$144B
$7.18M 0.04%
75,869
-4,620
-6% -$437K
BX icon
314
Blackstone
BX
$104B
$7.12M 0.04%
41,668
-1,978
-5% -$339K
THC icon
315
Tenet Healthcare
THC
$22.2B
$7.07M 0.04%
34,816
+10,310
+42% +$1.83M
SLB icon
316
SLB Ltd
SLB
$72.7B
$7.06M 0.04%
205,363
-3,042
-1% -$106K
ORKA
317
Oruka Therapeutics
ORKA
$5.31B
$7.06M 0.04%
366,994
+250,296
+214% +$3.71M
ORA icon
318
Ormat Technologies
ORA
$5.8B
$7.05M 0.04%
73,220
-13,353
-15% -$1.2M
DASH icon
319
DoorDash
DASH
$84.3B
$7.03M 0.04%
25,846
+1,180
+5% +$296K
GM icon
320
General Motors
GM
$80.9B
$6.93M 0.04%
113,688
+4,136
+4% +$231K
GIL icon
321
Gildan
GIL
$9.49B
$6.78M 0.04%
117,326
-7,995
-6% -$428K
SYRE icon
322
Spyre Therapeutics
SYRE
$8.5B
$6.78M 0.04%
404,362
+158,332
+64% +$2.58M
SRE icon
323
Sempra
SRE
$58.1B
$6.78M 0.04%
75,307
-15
-0% -$1.22K
ALV icon
324
Autoliv
ALV
$9.14B
$6.72M 0.04%
+54,397
New +$6.51M
AYI icon
325
Acuity Brands
AYI
$9.99B
$6.64M 0.03%
19,288
-497
-3% -$158K

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.